ADAM19 | ADAM metallopeptidase domain 19 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Mixed |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM21 | ADAM metallopeptidase domain 21 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM23 | ADAM metallopeptidase domain 23 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM29 | ADAM metallopeptidase domain 29 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM30 | ADAM metallopeptidase domain 30 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADAM32 | ADAM metallopeptidase domain 32 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM33 | ADAM metallopeptidase domain 33 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ADAM7 | ADAM metallopeptidase domain 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM9 | ADAM metallopeptidase domain 9 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS17 | ADAM metallopeptidase with thrombospondin type 1 motif, 17 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTS18 | ADAM metallopeptidase with thrombospondin type 1 motif, 18 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Mixed |
ADAMTS3 | ADAM metallopeptidase with thrombospondin type 1 motif, 3 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Mixed |
ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif, 4 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL5 | ADAMTS-like 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAP1 | ArfGAP with dual PH domains 1 | Predicted intracellular proteins
| | | | | Mixed |
ADARB1 | Adenosine deaminase, RNA-specific, B1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADAT2 | Adenosine deaminase, tRNA-specific 2 | Predicted intracellular proteins
| | | | | Mixed |
ADCK2 | AarF domain containing kinase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY1 | Adenylate cyclase 1 (brain) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADCY10 | Adenylate cyclase 10 (soluble) | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY4 | Adenylate cyclase 4 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADCY5 | Adenylate cyclase 5 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY6 | Adenylate cyclase 6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY7 | Adenylate cyclase 7 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ADCY9 | Adenylate cyclase 9 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCYAP1 | Adenylate cyclase activating polypeptide 1 (pituitary) | Predicted secreted proteins
| | | | | Tissue enhanced |
ADCYAP1R1 | Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADI1 | Acireductone dioxygenase 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADIG | Adipogenin | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADIPOR1 | Adiponectin receptor 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADIPOR2 | Adiponectin receptor 2 | Predicted membrane proteins
| | | | | Expressed in all |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADORA2A | Adenosine A2a receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |